4 min read Scientists are using CRISPR-Cas9 technology to permanently turn off two iver genes, PCSK9 and angiopoietin-like protein 3. Both are common drug targets for lowering LDL cholesterol levels. Small clinical trials show promising results with creating a ‘one and done’ treatment. Turning off the PCSK9 gene lowered cholesterol levels by 62 percent. Turning off angiopoietin-like protein 3 lowered cholesterol by nearly 50 percent. Heart doctors find “incredible potential” in gene therapy and a future where people may not need daily cholesterol-lowering pills. GETTING A DIAGNOSIS of high cholesterol is not fun. It requires a revamp of lifestyle basics like how you eat and making sure you're taking medications on time. Not to mention the never-ending worry of what would happen if cholesterol levels don't improve. Because no one wants a future filled with potential stroke and heart attacks . Cue this radical, ingenious method that sounds like something out of The Twilight Zone.…